Printing the Future of Therapeutics in 3D
May 6-8, 2019
Peter Wall Institute for Advanced Studies
Vancouver, BC, Canada
FOSTERING RELATIONSHIPS AND DEVELOPING COLLABORATIONS
PFT3D is an exclusive roundtable event centered around facilitating discussion and collaboration on the development of commercially and clinically relevant life-saving tissues.
ROUNDTABLE INFORMATION
Aspect Biosystems and The University of British Columbia are proud to be co-organizing the third annual International Research Roundtable on Printing the Future of Therapeutics in 3D (PFT3D).
Last year’s inaugural event saw speakers from a wide variety of both academia and industry to discuss the amazing potential and applications of 3D bioprinting. This year, the roundtable will take place over 3 days and includes 17 speakers, covering four key areas:
Functional biofabricated tissues for disease modeling, therapeutic discovery, and regenerative medicine
Platform technologies to recreate biological function
Biomaterials for the development of functional tissues
An industry perspective on tissue engineering technologies
By the end of this meeting, we want you to leave with new inspirational ideas on groundbreaking projects, new partners and opportunities for collaboration, and a fresh perspective on the needs of industry and the translation of academic research.
In addition to our roundtable talks, there will be focused discussion sessions to address a variety of key challenges in our industry and facilitated networking sessions to stimulate interactions.
2019 SPEAKERS
(more to be announced soon!)
Organizing Committee
Tamer Mohamed
President & CEO, Aspect Biosystems
Christian Naus
Professor Emeritus, University of British Columbia
Sam Wadsworth
Chief Scientific Officer, Aspect Biosystems
Natalie Korenic
Marketing & Communications Manager, Aspect Biosystems
Speakers
Heather Burkin
Assistant Professor, Department of Pharmacology University of Nevada, Reno School of Medicine
Mehmet R. Dokmeci
Associate Adj Professor, Radiology, Medical School, University of California - Los Angeles
Jason Ekert
Head Complex In Vitro Models, In Vitro/In Vivo Translation, Research, GlaxoSmithKline
Paul C. Goodwin
Science Director, GE Healthcare, Life Sciences
Ken-ichi Hamada
Program Manager, JSR-Keio University Medical and Chemical Innovation Center, JSR Corporation
Jinah Jang
Assistant Professor, Pohang University of Science and Technology (POSTECH)
Anna Jezierski
Research Officer, Human Health Therapeutics Research Centre, National Research Council Canada
Timothy J. Kieffer
Professor, Cellular & Physiological Sciences and Surgery, University of British Columbia, Diabetes Research Group Leader, School of Biomedical Engineering, Life Sciences Institute
Tamer Mohamed
President & CEO, Aspect Biosystems
Carlos Mota
Assistant Professor, Maastricht University, MERLN Institute, Dept. of Complex Tissue Regeneration, The Netherlands
Massimiliano Paganelli
Pediatric Hepatologist, Sainte-Justine University Hospital Center, Assistant Professor of Pediatrics, Université de Montréal, Founder, Morphocell Technologies Inc.
Adrian West
Assistant Professor, Department of Physiology and Pathophysiology, University of Manitoba
Stephanie Willerth
Associate Professor and Canada Research Chair in Biomedical Engineering, University of Victoria
Tim Woodfield
Assoc Professor, University of Otago, New Zealand Director CReaTE Group, Department of Orthopaedic Surgery Director UOtago Centre for Bioengineering & Nanomedicine
2018 SPEAKERS
- Elizabeth Aisenbrey
Postdoctoral Trainee in Vascular Surgery and Biomedical Engineering, University of Wisconsin - David Ballard
Radiology Resident, Mallinckrodt Institute of Radiology, Washington University School of Medicine - Andreas R. Baudy
Assoc. Principal Scientist, Safety Assessment Department, Merck & Co., Inc - Robert A. Blake
Scientist in Biochemical and Cellular Pharmacology, Genentech, Inc. - Akhilesh K. Gaharwar
Assistant Professor of Biomedical Engineering, Texas A&M University - Sepideh H. Hagvall
Associate Principal Scientist, AstraZeneca and Adjunct Professor in Molecular Biology, Skövde University, Sweden
- Jeremy Hirota
Canada Research Chair in Respiratory Mucosal Immunology, Assistant Professor of Medicine – McMaster University, Assistant Professor of Medicine (Affiliate) – UBC - Jinah Jang
Assistant Professor, Pohang University of Science and Technology (POSTECH) - Anna Jezierski
Research Scientist, Human Health Therapeutics, National Research Council Canada - Jean-Louis Klein
Director, Target & Pathway Validation, GlaxoSmithKline - Tamer Mohamed
President & CEO, Aspect Biosystems - John F. Trant
Assistant Professor, Department of Chemistry and Biochemistry and the Canadian Centre for Alternatives to Animal Methods, University of Windsor
- Stephanie Willerth
Associate Professor and Canada Research Chair in Biomedical Engineering, University of Victoria - Bill Yackabonis
Technical Manager, Autodesk - Peter Zandstra
Director, School of Biomedical Engineering and Professor, Department of Medical Genetics, UBC - Boyang Zhang
Assistant Professor, Department of Chemical Engineering, McMaster University - Yu Shrike Zhang
Associate Bioengineer and Faculty, Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
VENUE & HOSTS
We are proud to be hosting this International Research Roundtable at the Peter Wall Institute for Advanced Studies on the beautiful University of British Columbia (UBC) campus in Vancouver, BC.
The Peter Wall Institute for Advanced Studies at the University of British Columbia (UBC) provides funding opportunities and an intellectual environment scholars are free to pursue the collaborative exchange of ideas beyond disciplinary boundaries.
The Institute’s goal is to stimulate creative, innovative research that makes important advances in knowledge, and to share or implement these ideas through ongoing community engagement. The Institute achieves this by supporting a highly collaborative environment at UBC where scholars have the opportunity to exchange ideas with national and international scholars, develop new thinking and engage in intellectual risk-taking.
The University of British Columbia is a global centre for research and teaching, consistently ranked among the 40 best universities in the world. Since 1915, UBC’s West Coast spirit has embraced innovation and challenged the status quo. Its entrepreneurial perspective encourages students, staff and faculty to challenge convention, lead discovery and explore new ways of learning. At UBC, bold thinking is given a place to develop into ideas that can change the world.
Aspect Biosystems is a privately held biotechnology company pioneering microfluidic 3D bioprinting of living, human tissue. The company’s proprietary technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to enable the creation of living, human tissues for medical research, therapeutic discovery, and regenerative medicine products.
ACCOMMODATION
Accommodation is booked for all speakers at Ponderosa Suites on UBC campus, May 6-8, 2019, unless otherwise specified. For non-speaking attendees who need assistance with accommodation, please contact Natalie at nataliek@aspectbiosystems.com.
From Ponderosa Suites, it is a short 8 minute walk across UBC campus to the main venue, the Peter Wall Institute for Advanced Studies (6331 Crescent Rd).
Ponderosa Suites
2075 West Mall
Vancouver, BC
(on UBC campus)
2018 SPONSORS
Thank you to our sponsors. Please contact us if you are interested in sponsorship opportunities.
